Circular RNA Biology: Detection, Function and Experimental Pitfalls
Introduction: A Real Molecule With a Fragile Literature
Circular RNAs are produced by back-splicing, in which a downstream splice donor joins an upstream acceptor, creating a covalently closed loop. They are abundant in some tissues, stable because they lack free ends, and in a few well-documented cases functionally important.
They are also the subject of a large literature in which the molecule's existence, its abundance, and its function are established with unequal rigor. Three problems recur: detection artifacts (signals that look circular but are not), abundance confusion (copy numbers too low to support a stoichiometric function), and overexpression artifacts (phenotypes produced by non-physiological levels).
Part 1 — Biogenesis, Briefly
| Route | Mechanism | Notes |
|---|---|---|
| Exon skipping / lariat-driven | Back-splicing joins flanking exons | Most common in mammals |
| Intron pairing (reverse complementarity) | Flanking intronic repeats bring splice sites together | Explains many tissue-specific circRNAs |
| RBP-mediated | RNA-binding proteins bridge splice sites | Candidate-specific |
| tRNA/intron lariats | Non-canonical circularization | Distinct biology from exon-derived circRNAs |
Flanking intronic repeats and RBP binding are the two features most predictive of whether a given exon circularizes — useful when deciding which candidate to pursue.
Part 2 — Detection: Where False Positives Come From
| Method | What it detects | Principal artifact |
|---|---|---|
| Divergent primers (RT-PCR) | A back-splice junction | Genomic rearrangements and tandem duplications produce the same product |
| RNase R resistance | Closed, exonuclease-resistant RNA | Incomplete digestion; structured linear RNAs can appear resistant |
| Short-read RNA-seq + circRNA callers | Back-splice junction reads | False calls from misalignment; low abundance under-detected |
| Long-read sequencing | Full-length circular sequence | Depth and library bias |
| Microarray / Nanostring panels | Predicted junctions | Cross-hybridization to linear isoforms |
The validation combination that holds up: divergent primers confirmed by Sanger sequencing of the junction, RNase R resistance with a linear control, and — where available — long-read confirmation. Two of the three, not one.
The most common artifact is a genomic duplication or rearrangement that produces a junction indistinguishable from a back-splice event by PCR alone. Sequencing the junction and checking the genomic locus resolves it.
Part 3 — Abundance: The Constraint Nobody Reports
CircRNA function claims often require stoichiometry: a sponge must be present at comparable copy number to its target miRNA; a scaffold must be present at sufficient concentration to assemble complexes.
Practical measurements rarely reported:
- • Absolute copies per cell, from spike-in normalized quantification.
- • Ratio to the linear isoform from the same locus.
- • Ratio to the proposed interaction partner.
A circRNA present at a few copies per cell cannot sponge a miRNA present at hundreds. Papers that omit these numbers cannot support stoichiometric claims, which is the majority of the sponge literature.
Part 4 — Which Function Claims Survive
| Claim | Strength of evidence required |
|---|---|
| "This circRNA is expressed in tissue X" | Junction sequencing, RNase R, abundance |
| "It binds protein Y" | RIP or CLIP with linear controls; stoichiometry |
| "It sponges miRNA Z" | Absolute copy numbers for both, plus de-repression of targets |
| "It is translated" | Ribosome profiling or mass spectrometry evidence of the junction peptide |
| "It is required for phenotype" | Loss-of-function with rescue; not overexpression alone |
The fifth row is the load-bearing one. Overexpression of a circRNA to high levels will produce phenotypes through sequestration of almost any abundant RNA-binding protein; that is a property of the experiment, not necessarily of the molecule.
Part 5 — Experimental Pitfalls
- • Overexpression artifacts. Plasmid-driven circRNA expression can exceed physiological levels by orders of magnitude; phenotypes do not transfer.
- • Back-splice junction effects. Overexpressed minigene constructs can generate linear species from the same vector; verify what is actually produced.
- • siRNA against a junction. Knockdown of a circRNA with siRNA risks silencing the linear isoform if the siRNA also matches it; design junction-specific reagents and verify specificity.
- • Knockout of the locus. Deleting the genomic region removes the linear isoform too; interpret as a locus-level perturbation unless the circularization signal is specifically disrupted.
- • Translation claims. Detection of a junction-spanning peptide requires mass spectrometry with a synthetic standard, not just a predicted ORF.
Part 6 — A Minimal Standard for a circRNA Paper
- Junction sequence confirmed (Sanger or long-read).
- RNase R resistance with a linear control; genomic locus checked for rearrangement.
- Absolute abundance and ratio to linear isoform.
- Loss-of-function, not only gain-of-function.
- For interaction claims, stoichiometry of both partners.
- For translation claims, peptide-level evidence.
Papers that meet all six exist and are convincing. Papers that meet only the first two are describing expression, which is a legitimate but much smaller claim.
Need circRNA claims tested at physiological levels?
EDITGENE builds models for circRNA work: locus-level and circularization-specific perturbations, isogenic lines with verified junction sequences, and quantification with spike-in standards for absolute abundance.
Tell us the circRNA and the claim. Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Detection performance varies by method, abundance, and sequence; junction-level confirmation is required before a circular species is reported.
Function claims require loss-of-function evidence and, for stoichiometric mechanisms, absolute abundance measurements for both partners.
Selected references for further reading
- • Kristensen LS, et al. The biogenesis, biology and characterization of circular RNAs. Nature Reviews Genetics. 2019;20:675–691.
- • Jeck WR, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141–157.
- • Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nature Reviews Genetics. 2016;17:679–692.
- • Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nature Reviews Molecular Cell Biology. 2020;21:475–490.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »